Skip to content

Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04879927
Acronym
RESOURCE
Enrollment
125
Registered
2021-05-10
Start date
2021-05-17
Completion date
2023-04-01
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Gastrointestinal Cancer, Lung Cancer

Keywords

Breast Cancer, Lung Cancer, Gastrointestinal Cancer

Brief summary

The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal cancer.

Detailed description

This research study is an intervention assessment; this is the first-time investigators are examining the impact of screening for resource needs followed by customized resource matching at Dana-Farber Cancer Institute. * The research study procedures include screening for social determinants of health (resource) needs and, depending on study group, resource matching. * Participants will be randomized into one of two groups. * Usual Care or Usual Care with customized resource matching. It is expected that about 125 participants will take part in this research study.

Interventions

OTHERResource Matching

Resource staff involved in the customized resource matching arm of the intervention will include staff from DFCI Patient Services and DFCI Financial Counseling. Financial counseling will support patients with financial resource needs. DFCI Patient Services will provide assistance for all other patient Social Determinants of Health needs.

OTHERUsual Care

Patients randomized to the control group will receive a pre-existing pamphlet detailing DFCI resources.

Sponsors

Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eligible patients will be adults age 18 or older, able to consent, scheduled for a new patient consultation in DFCI BOC, TOP or GCC. To select for patients from demographic groups vulnerable to SDoH needs, two different groups will be eligible to participate. * Group A * BIPOC (Black, Latinx, Native American or Pacific Islander) * LEP Spanish-speaking (As indicated by the EHR) * Low SES (from zip code with median household income \<$32,000/year) OR * Age 70+ * Group B * Any one NPIQ response indicating SDoH need * Health literacy/numeracy, Caregiving/relationships, OR Finances

Exclusion criteria

\- Group A and B \-- Patients not continuing care at Dana Farber Cancer Institute

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients Treatment Interruption30 DaysNumber of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)
Rate of Treatment Interruption00 DaysRate of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026